Home/Filings/4/0001437749-23-018979
4//SEC Filing

Scott John K Jr. 4

Accession 0001437749-23-018979

CIK 0000810509other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 10:46 AM ET

Size

6.3 KB

Accession

0001437749-23-018979

Insider Transaction Report

Form 4
Period: 2023-06-29
Transactions
  • Award

    Common Stock

    2023-06-29$0.09/sh+12,200,000$1,073,60031,755,832 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    10,139
  • Series G Redeemable Preferred Stock

    2,270
Footnotes (2)
  • [F1]Navidea entered into a Letter Agreement with the Reporting Person, pursuant to which the Company agreed to repay $1,073,600 principal amount of an outstanding Term Note by issuing to the Reporting Person 12,200,000 shares of Common Stock, based on the closing stock price of $0.088 per share on June 28, 2023.
  • [F2]Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed tohave shared voting and/or dispositive power with respect to such shares.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001753763

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 10:46 AM ET
Size
6.3 KB